Viking Therapeutics, Inc.

US$26.84As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VKTXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 37.93%
Div yield —
ROE (96.37%)
Biotechnology
Beta (5Y) 0.75
PE TTM —
TSR TTM (29.52%)
Mkt cap US$3.423B
ROIC (52.07%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$28
4.61%
(58.45%)
Hold 6|12|5|9|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.27
0.28
0.27
0.27
(3.48%)
5.82%
(3.89%)
0.48%
Revenue$M
390.5
394.7
389.3
406.0
8.55%
8.09%
1.84%
7.93%
Peers (US$3.423B)
Cap (US$)
PE
3.409B
26.88x
Capital
TTM
5Y
10Y
Leveragex
8.779
10.62
10.28
EBIT/Intx
0.869
0.273
0.262
Own earn%
46.62
(77.23)
(63.05)
Sh yield%
20.81
21.30
19.68
Owners
Insiders/Inst%
3.14
54.30
Short interest%
5.67
SBC / revenue%
3.90
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
28–39
$1 testx
—
Incr. ROIC%
4